| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |